#38. Cholesterol increases bone marrow tumour burden in myeloma in vivo and promotes myeloma cell viability and bortezomib resistance ex vivo

• B. Gámez,
• E.V. Morris,
• S. Olechnowicz,
• A. Sowman,
• C. Turner,
• S.T. Lwin,
• Z. Kaya,
• J.R. Edwards,
• C.M. Edwards

Affiliations

B. Gámez

Nuffield Department of Surgical Sciences, Botnar Research Centre, University of Oxford, Oxford, UK

E.V. Morris

Nuffield Department of Surgical Sciences, Botnar Research Centre, University of Oxford, Oxford, UK

S. Olechnowicz

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK

A. Sowman

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK

C. Turner

Nuffield Department of Surgical Sciences, Botnar Research Centre, University of Oxford, Oxford, UK

S.T. Lwin

Nuffield Department of Surgical Sciences, Botnar Research Centre, University of Oxford, Oxford, UK

Z. Kaya

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK

J.R. Edwards

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK

C.M. Edwards

Nuffield Department of Surgical Sciences, Botnar Research Centre, University of Oxford, Oxford, UK